Results 231 to 240 of about 573,785 (398)
Impact of Height Exponents: A New Diagnostic Lens for Left Ventricular Hypertrophy? [PDF]
Lian X, Lu M.
europepmc +1 more source
Ramipril prevents left ventricular hypertrophy with myocardial fibrosis without blood pressure reduction: a one year study in rats [PDF]
Wolfgang Linz +4 more
openalex +1 more source
Metabolic syndrome is characterized by abdominal obesity, hyperglycemia, dyslipidemia, and hypertension. Bioactive compounds extracted from herbs, tea, and coffee using microbial cell factories, particularly resveratrol and caffeic acid, have demonstrated remarkable potential in the management of metabolic syndrome, offering innovative solutions for ...
Tao Li +7 more
wiley +1 more source
Monocyte-to-Neutrophil Ratio as an Immunological Marker of Left Ventricular Hypertrophy in Children with Primary Hypertension. [PDF]
Dziedzic-Jankowska K +6 more
europepmc +1 more source
Patterns of diastolic dysfunction in left ventricular hypertrophy.
Leonard M. Shapiro, D G Gibson
openalex +1 more source
Left Ventricular Hypertrophy With Strain and Aortic Stenosis
Anoop S. V. Shah +14 more
semanticscholar +1 more source
Plasma metabolome‐wide Mendelian randomization analysis established a causal link between tyrosine and arrhythmia. GWAS meta‐analysis identified tyrosine‐associated loci linked to cardiovascular risk factors. Animal studies confirmed that oral tyrosine intake modulates heart rhythm via adrenergic signaling activation.
Zhikang Cao +7 more
wiley +1 more source
Identifying PRKAG2 syndrome-a rare cause of wolff-Parkinson-white syndrome and left ventricular hypertrophy: a case report. [PDF]
Jang JH +4 more
europepmc +1 more source
BP control and left ventricular hypertrophy regression in children with CKD.
J. Kupferman +6 more
semanticscholar +1 more source
Abstract Mavacamten, a cardiac myosin inhibitor, is primarily metabolized by the cytochrome P450 (CYP) enzymes CYP2C19 and CYP3A4, and coadministration with strong CYP3A4 or CYP2C19 inhibitors was contraindicated in patients with obstructive hypertrophic cardiomyopathy (HCM) in the US Prescribing Information. This study assessed the safety and efficacy
Samira Merali +7 more
wiley +1 more source

